ModlinIMSandorA. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813–829.
2.
Albores-SaavedraJBatichKHossainSHensonDESchwartzAM. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program. Ann Diagn Pathol.2009;13(6):378–383.
3.
KlöppelG. Neuroendocrine neoplasms: dichotomy, origin and classifications. Visceral Med. 2017;33(5):324–330.
4.
SchimmackSSvejdaBLawrenceBKiddMModlinIM. The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbeck's Arch Surg.2011;396:273–298.
5.
UccellaSLa RosaSVolanteMPapottiM. Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms. Endocr Pathol.2018;29:150–168.
6.
SquillaciSMarchioneRPiccolominiM, et al.Well-differentiated neuroendocrine carcinoma (malignant carcinoid) of the extrahepatic biliary tract: report of two cases and literature review. APMIS. 2010;118(8):543–556.
7.
MichalopoulosNPapavramidisTSKarayannopoulouGPliakosIPapavramidisSTKanellosI. Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res.2014;20:765–775.
8.
MaitraAKruegerJETascilarM, et al.Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol.2000;24(11):1501–1510.
9.
NoronhaYSRazaAS. Well-differentiated neuroendocrine (carcinoid) tumors of the extrahepatic biliary ducts. Arch Pathol Lab Med.2010;134(7):1075–1079.